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In studies to date, the C3H/HeJ strain of mice has been shown to be unresponsive 
to all the investigated aspects of endotoxicity exerted by phenol extracted endotoxic 
lipopolysaccharides (LPS), e.g., adjuvant action (1, 2), mitogenicity (3-5), polyclonal 
B  lymphocyte Ig synthesis  (1,  6),  endotoxic shock  (5), enhancement of nonspecific 
resistance to infection (7), leukocyte changes (8), protection against X-irradiation (9), 
negation of tolerance induction (1, 10), and inducement of glucocorticoid antagonizing 
factor (11). Watson and Riblet have published evidence that this unresponsiveness of 
the C3H/HeJ mouse is determined by a  single autosomal, dominant  gene which is 
not linked to the H2 or heavy chain allotype loci (4). 
On the other hand, several endotoxic functions have been shown to be elicited in 
the C3H/HeJ mouse by LPS extracted with butanol or trichloroacetic acid  (Boivin 
type) (1,  12). This product has been shown to contain a low molecular weight protein 
contaminant which probably is responsible for the observed stimulation of mitogen- 
icity,  polyclonal  B-cell  activation,  and  inhibition  of tolerance  induction  (13,  14). 
Despite the presence of this protein, however, the butanol extracted LPS was incapable 
of adjuvant action in this mouse strain. 
In contrast to the adjuvant action of bacterial endotoxins, which occurs when LPS 
is given with antigen, an opposite, suppressive effect was noted in rabbits when LPS 
was  introduced  before the  antigen  (15).  Franzl  and  McMaster,  in  their  thorough 
study of this effect in mice, noted that  the dose-dependent inhibition of hemolysin 
production was paralleled by a % decrease in the normal weight of the thymus when 
LPS was  given  1-2  days  before antigen  (16,  17). Also  negated was  the  early  and 
excessive proliferation of large  pyroninphilic cells in  the white pulp  of the spleen, 
cortical regions of lymph nodes, and activated germinal centers that is characteristic 
of mice injected with endotoxin and antigen together (18).  Recent renewed interest in 
this phenomenon has resulted in an oscillating effect with time of injection of LPS 
relative to antigen in ICR mice being noted (19).  In addition, Persson has reported 
evidence that LPS suppression in the A/Sn/C57BI F1 hybrid was due to the generation 
of nonspecific, B-suppressor cells  (20), while others have shown that  the secondary 
response of several mouse strains could be suppressed  if the  LPS was  given either 
before (21)  or after (3) antigen. The latter authors reported, however, that  the LPS 
did not suppress antibody-forming cells in the C3H/HeJ mouse when  1/zg was given 
1 day after antigen. 
* Supported by U. S. Public Health Service  grant Ca 13701, and the Max Cutcheon Fund, University 
of Michigan Honors  Council. 
J. ExP. M~D. ©The Rockefeller  University  Press ' 0022-1007/78/1001-108151.00  1081 
Volume 148  October  1978  1081-1086 1082  G.  P.  HAAS ET  AL.  BRIEF DEFINITIVE REPORT 
To extend our characterization of the unresponsiveness of the C3H/HeJ  mouse to 
the action of LPS, we tested the capacity of a protein-free and a Boivin type endotoxin 
to induce suppression of the primary immune  response in this unique mouse strain. 
Surprisingly, suppression of plaque-forming ceils (PFC) formation was readily induced 
with both preparations and found to be transferrable with spleen cells of LPS treated 
C3H/HeJ  mice. To our knowledge, this is the first report of an effect by a protein-free 
LPS on the immune response in the heretofore unresponsive C3H/HeJ  mouse. 
Materials and  Methods 
Mice.  The  C3H/HeJ  mice and  their responsive genetic counterpart, the C3H/HeB/FeJ 
mice were purchased from The Jackson Laboratory, Bar Harbor, Maine. After establishing the 
endotoxin induced suppression, these mice were bred in our own laboratory by brother-sister 
matings. The mice were utilized at 2- to 9-mo of age. 
Antigen.  Sheep erythrocytes (SRBC)  were obtained  from  Colorado Serum  Co.,  Denver, 
Colo.  as sterile lamb's blood in  Alsever's solution. The  cells were washed  three  times with 
Moller's modified salt solution before use. 5  ×  108 cells were injected intraperitoneally; in the 
in vitro experiments, 107 SRBC were added to each culture dish. 
Suppressive Agents.  Lipopolysaccharide was prepared by the Boivin procedure from Serratia 
marcescens, and the protein-free, purified glycolipid from Salmonella minnesota, R  595.  Immuno- 
chemical characterization of the former (15) and the latter (22) has been published previously. 
20  btg of the  Boivin preparation and  50  #g of the  glycolipid after sonication were  injected 
intraperitoneally, while 0.02 #g of the former or 0.05 p.g of the latter were added to in vitro 
culture dishes. Polyadenylic acid, lot 81, and polyuridylic acid, lot 92, were purchased as the 
potassium and ammonium  salts, respectively, from Miles Laboratories, Inc., Miles Research 
Products, Elkhart, Ind. Equal amounts of the individual homoribopolymers were combined in 
0.15  M  NaCI at room temperature for  1 h; 200/~g of the complex was injected i.p. into each 
mouse.  Injection  of each  agent  was  performed  on  day  -2  or 0  in  relationship to  antigen 
administration. 
Measurement of Suppression.  Spleen cells were removed from C3H/HeJ  mice sacrificed by 
cervical dislocation and single cell suspensions were prepared on day 0 for the in vitro tests and 
on day 4 for the in vivo experiments. Cells removed on day 0 were cultured according to the 
technique of Mishell and Dutton (23). They were suspended to a concentration of 107 cells/ml 
and dispensed in  1-ml portions into 35  X  10-mm Falcon plastic culture dishes. The transfer 
experiments utilized 0.5 ml (5  ×  106) of normal cells from uninjected mice mixed with 0.5 ml 
(5  ×  106) of cells from mice previously treated with endotoxin on day -2. 5  ×  106 SRBC were 
then added to each culture dish on day 0, and the culture plates were incubated for 4 days in 
a gas tight humidity chamber containing 7% 02,  10% CO2, and 83% Nz. They were rocked at 
7 cycles/min at 37°C and fed daily with a pH balanced nutritional supplement. The PFC from 
both the in vitro and in vivo studies were assayed using the localized hemolysis in gel technique 
as modified by Coutinho et al. (24). 
Results 
The  effect  of injection  into  C3H/HeJ  mice  of a  Boivin  type  endotoxin  and  a 
purified glycolipid endotoxin two days before antigen is compared in Fig. 1 with these 
products  added with  antigen.  It  may  be seen  that,  as expected, neither  the  Boivin 
type  LPS  or  the  glycolipid acted  as  an  adjuvant  in  this  strain  when  introduced 
together with antigen. Each of these lots of LPS previously had been shown to act as 
an adjuvant in numerous other strains of mice. Poly A:U, a known non-LPS adjuvant, 
served as the positive reference control, and  documented  the selective nature of the 
deficiency to LPS in this strain. However, when either LPS was injected 2 days before 
antigen,  a  profound  inhibition  averaging  75%  or  better  was  observed.  Poly  A:U, 
whose  immunorepertoire  also  includes  suppression  of  PFC  when  injected  before G.  P.  HAAS  ET  AL. 
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FIG.  1.  Inhibition  of PFC  formation by i.p. injection of 20 #g Boivin type LPS or 50 #g glycolipid 
2 days before i.p. injection  of 5  x  l0  s SRBC.  A:U  =  200 g  polyadenylic-polyuridylic  acid complex 
injected  i.p.  on  days  indicated.  Mice  sacrificed  and  PFC  determined  4  days  after  antigen.  Mean 
number  of PFC  in control spleens  =  1,630  +  273. Values are  +  standard  deviation. 
TABLE  I 
Suppression of PFC Response of Normal C3H/HeJ Spleen Cells by Endotoxin 
Exposed C3H/HeJ Spleen Cells 
Exposure to agent  Splcen cells iz~. culture  8upprcs.slon of PFC* 
% 
Day -2~c  LPS Treated  65 ±  13 
LPS Treated +  normal (1:1)  51  ±  12 
Glycolipid treated  49 ::t: 8 
Glycolipid treated  +  normal (l:l)  44 ±  17 
Day 0~  LPS Treated  0 ::t: 0 
Glycolipid treated  3 ::t: 4 
* Average  of three experiments  ±  standard deviation. 
~c 20 gg LPS or 50 #g glycolipid injected i.p. 2 days before removal and culture of 107 total spleen cells 
with  10; SRBC/cuhure dish. 
§ 0.02 v.g LPS or 0.05 #g glycolipid plus 107 SRBC added in vitro to 107 cultured spleen cells. 
antigen (25), again served as a positive reference control. Thus, although LPS failed 
to function as an adjuvant  in C3H/HeJ mouse in accordance with what  has been 
reported previously (1, 2), both preparations were capable of inducing the opposite 
action, suppression. 
To determine whether such suppression might be transferrable via spleen cells and 
dampen  antibody  synthesis  by  normal  spleen  cells,  coculture  experiments  were 
performed with a  1  : 1 mixture of spleen cells from mice previously injected with LPS, 
and  normal  cells,  cultured  with  antigen.  As  may be  seen  in  Table  I,  addition  of 
antigen in vitro to cultured spleen cells removed from C3H/HeJ mice injected with 
either glycolipid or Boivin type LPS 2 days earlier, resulted in a 49-65% inhibition of 
PFC formation. Cocuhure of 5  ×  106 of such inhibited cells with an equal number of 1084  G.  P.  HAAS  ET  AL,  BRIEF  DEFINITIVE  REPORT 
normal  spleen  cells  from  uninjected  C3H/HeJ  mice  resulted  in  transfer  of  this 
suppressive property, diminishing  the normal  PFC  capability by a  similar order of 
magnitude, 44-51%. In contrast, coculture of spleen cells from mice receiving LPS on 
day 0  did  not  result  in  any inhibition  of the normal  cell  response.  Parallel control 
studies in C3H/HeB/HeJ mice, which are susceptible to the action of LPS, showed 
the expected 56% inhibition when injected with LPS on day -2, and enhancement of 
the day 4 PFC when either LPS was introduced on day 0 together with antigen (data 
not shown). 
Mitogenicity  (stimulation index)  of the glycolipid was minimal for spleen cells of 
the  C3H/HeJ  strain,  but  averaged  approximately  20-fold in  the  C3H/HeB/FeJ 
strain.  The  Boivin  type  LPS  was  not  significantly  active  in  either  of these  mice. 
However, both the Boivin preparation and the glycolipid were strongly mitogenic for 
reference BALB/c spleen cells (23 and 22-fold, respectively). 
Discussion 
The above data  show  for the  first  time that  the C3H/HeJ  strain  of mice is  not 
refractory to all of the diverse biological activities of protein-free endotoxins derived 
from Gram negative bacteria. In previous studies, any biological action of LPS in this 
strain  could  be attributed  to a  protein  contaminant.  This  is  not  the case with  the 
inducement  of suppressor action as illustrated  in  this manuscript, since Chen  et al. 
(22)  have  analyzed  this  glycolipid  preparation  in  detail  and  indicated  it  to  be  a 
protein-free,  chloroform-methanol  soluble  complex  composed  of  lauric,  myristic, 
palmitic,  stearic,  and  beta-hydroxymyristic acids  with  only  trace  amino  acids.  Its 
biologic activities were comparable to the parent compound. 
The  greater  implication  of  these  data  are,  however,  that  the  suppressor  cell 
regulatory mechanism for the immune response induced  by LPS is under a  different 
genetic control than the helper function. In all studies to date, including this one, the 
C3H/HeJ mouse did not  respond to the profound adjuvant  action, as well as other 
properties  (e.g.,  mitogenicity),  of  LPS.  This  indicates  that  a  gene  product  (LPS 
receptor?) is absent or diminished in this mouse strain. Verification is provided by the 
work  of Melchers  et  al.  (personal  communication)  who  have  shown  that  in  the 
C3H/HeJ mouse only 1 in  10,000  B lymphocytes are reactive to LPS, as compared to 
a ratio of 1:3 in other strains. Consequently, a gene product(s) controlling suppression 
on the B cell may be different from that controlling other activities of LPS, or more 
likely, the LPS suppressive signal acts on a different target, the T  cell or macrophage. 
Thus, we hypothesize that the feature of non-B-cell responsiveness to LPS still holds 
in this unique mouse strain with the induced suppressor cell being probably a T  cell 
or macrophage. Current experiments are designed to test this hypothesis. 
Summary 
The experiments described herein demonstrate the plaque-forming cell response of 
C3H/HeJ mice can be suppressed by a  Boivin type lipopolysaccharide (LPS)  and a 
deproteinized  glycolipid.  Suppression  was observed both  in  vivo and  in  vitro, and 
could be transferred to normal cells in coculture experiments. This newly discovered 
effect of LPS in C3H/HeJ mice indicates that the adjuvant and inhibitory action of 
LPS may be distinct phenomena which are under different genetic regulation. Thus, G.  P.  HAAS  ET AL.  BRIEF DEFINITIVE REPORT  1085 
the C3H/HeJ strain provides a convenient animal model for study of immunosuppres- 
sion  independent  of the  adjuvant  effect. 
The authors wish to thank Doctor Howard Lederman for helpful discussions. 
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